[Featured Stock] Withus Pharm, Soars on First Day of Listing... Surpasses IPO Price by 150%
[Asia Economy Reporter Jang Hyowon] Withus Pharmaceutical is showing a sharp rise on its first day of listing.
As of 9:49 AM on the 3rd, Withus Pharmaceutical is trading at 39,650 KRW, up 24.69% (7,850 KRW) from the opening price. This is 148.4% higher compared to the public offering price of 15,900 KRW.
Founded in 2004, Withus Pharmaceutical has primarily engaged in the manufacturing of generic drugs. It has secured profitability through formulation technology specialized for geriatric diseases and has continued to grow by acquiring high value-added product technologies such as first generics and dedicated facilities for cephalosporin antibiotics.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Last year, Withus Pharmaceutical posted sales of 51.7 billion KRW, operating profit of 10.9 billion KRW, and net profit of 8.6 billion KRW. Its operating profit margin was 21.1%, which is significantly higher than the average of 7-10% for listed pharmaceutical companies.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
